ADCV 01
Alternative Names: ADCV-01; Autologous dendritic cell vaccine - Ever Supreme Bio TechnologyLatest Information Update: 27 Jul 2022
At a glance
- Originator Ever Supreme Bio Technology
- Class Cancer vaccines; Dendritic cell vaccines; Immunotherapies
- Mechanism of Action Immunostimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Glioblastoma
Most Recent Events
- 27 Jul 2022 Phase-II development is ongoing in Taiwan (SC) (NCT04115761)